- Demographic and clinical data of the study participants.
| Parameters | Control group (n=28) | Celecoxib group (n=26) | P-value |
|---|---|---|---|
| n (%) | |||
| Gender | |||
| Male | 9 (32.1) | 9 (34.6) | 0.847 |
| Female | 19 (67.8) | 17 (65.3) | |
| Age (years), mean±SD | 42.04±8.95 | 45.92±5.07 | 0.058 |
| Weight (kg), mean±SD | 72.39±4.13 | 72.26±4.29 | 0.915 |
| Height (cm), mean±SD | 161.34±1.49 | 162.96±4.56 | 0.084 |
| BMI (kg/m2), mean±SD | 27.8±1.49 | 27.25±1.84 | 0.227 |
| Primary tumor | |||
| Colon | 21 (75) | 23 (88.5) | 0.203 |
| Rectum | 7 (25) | 3 (11.5) | |
| Metastatic site | |||
| Liver | 15 (53.6) | 19 (73.1) | 0.138 |
| Others | 13 (46.4) | 7 (26.9) | |
BMI: body mass index, SD: standard deviation